Issue 21, 2017, Issue in Progress

pH-sensitive polymeric micelles for the Co-delivery of proapoptotic peptide and anticancer drug for synergistic cancer therapy

Abstract

Mitochondria plays a vital role in a wide range of biological processes in human health and diseases. They are considered to be important organelles responsible for cellular apoptosis or programmed cell death. Therefore, the targeting of chemotherapy towards mitochondria would be highly desirable. Herein, we developed a pH-sensitive polymer that is designed for the subcellular co-delivery of anticancer drugs and therapeutic peptides to tumor cells. The amphiphilic copolymer poly(β-amino esters)-poly(ethylene glycol) was synthesized and conjugated with the dual-targeting proapoptotic peptide CGKRKD(KLAKLAK)2. The conjugate can self-assemble into a core–shell micellar structure at the physiological pH of 7.4. The anticancer drug docetaxel (DTX) was encapsulated inside the core of the micelles. The CGKRK peptide is specifically targeted to angiogenic blood vessels in tumors and tumor cells, whereby the micelles are efficiently internalized into tumor cells via an energy-dependent, lipid draft/caveolae-mediated endocytosis pathway. Once inside the acidic endosomal compartment, the stimuli-responsive micellar carriers disassemble and release both pharmacological agents. CGKRK efficiently transports D(KLAKLAK)2 towards mitochondria to trigger mitochondria-dependent apoptosis. DTX affects microtubulin for arresting the cancer cell cycle. Thus, the combination of DTX and the therapeutic peptide displayed a synergistic antitumor effect in an MCF-7 cell line.

Graphical abstract: pH-sensitive polymeric micelles for the Co-delivery of proapoptotic peptide and anticancer drug for synergistic cancer therapy

Supplementary files

Article information

Article type
Paper
Submitted
20 Nov 2016
Accepted
08 Feb 2017
First published
24 Feb 2017
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2017,7, 12886-12896

pH-sensitive polymeric micelles for the Co-delivery of proapoptotic peptide and anticancer drug for synergistic cancer therapy

A. Mozhi, I. Ahmad, C. I. Okeke, C. Li and X. Liang, RSC Adv., 2017, 7, 12886 DOI: 10.1039/C6RA27054A

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements